In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.

Source:http://linkedlifedata.com/resource/pubmed/id/9794447

J. Immunol. 1998 Nov 1 161 9 5087-96

Download in:

View as

General Info

PMID
9794447